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ABSTRACT
Objectives: To determine factors associated with
hospitalisation after community-acquired pneumonia
(CAP) among older adults in England, and to
investigate how these factors have contributed to
increasing hospitalisations over time.
Design: Cohort study.
Setting: Primary and secondary care in England.
Population: 39 211 individuals from the Clinical
Practice Research Datalink, who were eligible for
linkage to Hospital Episode Statistics and mortality
data, were aged ≥65 and had at least 1 CAP episode
between April 1998 and March 2011.
Main outcome measures: The association between
hospitalisation within 28 days of CAP diagnosis
(a ‘post-CAP’ hospitalisation) and a wide range of
comorbidities, frailty factors, medications and
vaccinations. We examined the role of these factors in
post-CAP hospitalisation trends. We also looked at
trends in post-CAP mortality and length of
hospitalisation over the study period.
Results: 14 comorbidities, 5 frailty factors and 4
medications/vaccinations were associated with
hospitalisation (of 18, 12 and 7 considered,
respectively). Factors such as chronic lung disease,
severe renal disease and diabetes were associated with
increased likelihood of hospitalisation, whereas factors
such as recent influenza vaccination and a recent
antibiotic prescription decreased the odds of
hospitalisation. Despite adjusting for these and other
factors, the average predicted probability of
hospitalisation after CAP rose markedly from 57%
(1998–2000) to 86% (2009–2010). Duration of
hospitalisation and 28-day mortality decreased over the
study period.
Conclusions: The risk factors we describe enable
identification of patients at increased likelihood of post-
CAP hospitalisation and thus in need of proactive case
management. Our analyses also provide evidence that
while comorbidities and frailty factors contributed to
increasing post-CAP hospitalisations in recent years,
the trend appears to be largely driven by changes in
service provision and patient behaviour.
INTRODUCTION
Hospitalisations for ambulatory care sensitive
conditions (ACSC, conditions which could
be treated outside of hospital) have
increased considerably over the past
decade.1 2 Pneumonia is one such condition,
with >56 000 more pneumonia admissions in
Strengths and limitations of this study
▪ Our novel use of large linked primary and sec-
ondary care data sets provided enriched patient
medical and therapeutic histories, and allowed
detailed identification of the determinants of hos-
pitalisation after community-acquired pneumonia
(CAP).
▪ The very large sample size, with more than
43 000 CAP episodes, enabled assessment of
multiple potential risk factors for hospitalisation
with precise estimation of relative risk.
▪ Using linked data also allowed us to distinguish
trends in the tendency to hospitalise patients
with CAP (the focus of this paper) from trends in
CAP hospitalisations due simply to increasing
CAP incidence.
▪ Our analyses suggested that frailty factors were
suboptimally recorded by general practitioners,
preventing full assessment of these factors and
highlighting the need for better capture of frailty
by practices.
▪ For similar reasons, analyses on the effect of
smoking were performed on a subset of the
data, due to previously described incomplete
recording of smoking status pre-2004.
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2010/2011 compared with 2001/2002.2 Most of this
increased burden is found among patients aged 65 years
and older who accounted for 70% of pneumonia admis-
sions in 2012/2013.3 In England, the recently intro-
duced Unplanned Admissions Enhanced Service
highlights the importance of proactive case management
in primary care of at-risk patients, many of whom are
expected to be older, to reduce ACSC hospitalisations.4 5
To date, risk factors for hospitalisation for
community-acquired pneumonia (CAP) have not been
quantiﬁed. Existing analyses based on stand-alone hospi-
talisation data are unable to compare hospitalised
patients with CAP to those who were treated in the com-
munity. They therefore cannot distinguish between
factors which affect a patient’s likelihood of hospitalisa-
tion after a CAP diagnosis from risk factors for develop-
ing CAP. Furthermore, hospitalisation data have
incomplete information on patients’ medical histories,
and contain little or no information on factors such as
alcohol and smoking habits, frailty, or medications pre-
scribed in the community. It is frequently hypothesised
that changes in comorbidities and frailty factors have
contributed to the increasing hospitalisation trends
for older individuals with CAP in the UK. Use of a
non-hospitalised comparison group would allow this
hypothesis to be tested, and to distinguish an increasing
tendency to hospitalise older patients with CAP from
increasing incidence of CAP among older adults.6
In this study, we used large linked general practice,
hospital admission and mortality data sets to assess a
variety of potential risk factors (comorbidities, medica-
tions and other factors) for hospitalisation after CAP
among older individuals in England. Use of the general
practice data enabled more complete capture of patient
histories than those derived from stand-alone hospital
records. We also investigated the risk over time of hospi-
talisation after a CAP diagnosis. The choice of a study
population who had been diagnosed with CAP allowed
us to examine speciﬁcally trends in hospitalisation after
CAP, independent of any trends in pneumonia inci-
dence. We assessed to what extent the patient factors
associated with hospitalisation explained these hospital-
isation trends. The linked mortality data enabled further
investigation into whether mortality rates in the 28 days
after CAP had changed over the same period, including
deaths occurring both in and outside hospital settings,
as a marker of CAP severity.
MATERIALS AND METHODS
Data sources
The Clinical Practice Research Datalink (CPRD, for-
merly GPRD) is a large database of UK general practice
records comprising a representative sample of around
8% of the UK population.7 8 Anonymised data in CPRD
include diagnoses (coded using Read codes), prescrip-
tions, referrals, tests and patient demographics. Over
50% of CPRD patients living in England have their
general practice records linked to Hospital Episode
Statistics (HES) which includes all inpatient National
Health Service (NHS) hospitalisations (coded using
International Classiﬁcation of Diseases (ICD)-10).9 Each
HES hospitalisation consists of one or more episode
denoting the time a patient is under the care of one
consultant. The data were also linked to Ofﬁce for
National Statistics (ONS) central mortality data to obtain
vital status and, if relevant, date of death.
Study population
We included patients who were registered with a CPRD
practice eligible for linkage to HES data, were aged
65 years or over between 1 April 1998 and 31 March 2011,
and who had a CAP episode recorded during that period.
Defining CAP episodes
The methods for deﬁning CAP illness episodes have
been described in detail elsewhere.6 In brief, lists of
Read (CPRD) and ICD-10 (HES) codes for pneumonia
and other lower respiratory tract infections (LRTIs) were
agreed by three clinical epidemiologists. Pneumonia
could be ﬁrst diagnosed either in general practice or
when presenting to hospital. In HES, in order to differ-
entiate between illness present at hospital admission and
subsequent hospital-acquired illness, only pneumonia
coded as the reason for admission (ie, the primary code
in the ﬁrst episode of a hospitalisation) was included in
the study. These HES pneumonia records were com-
bined with CPRD pneumonia records to determine
‘illness episodes’ whereby records within 28 days of each
other (or of an intermediate LRTI record) were deemed
part of the same infection.6 The earliest pneumonia
record in the ‘illness episode’ was the incident (diagno-
sis) date of pneumonia.
To be deﬁned as community-acquired, the CAP inci-
dent date needed to be ≥14 days after any HES inpatient
hospital discharge. All CAP episodes in eligible patients
during the study period were included in the study.
Defining hospitalisation after pneumonia
The outcome of interest was hospital admission
(deﬁned using HES) for any cause, on or up to 28 days
after the CAP diagnosis date. Thus, a CAP diagnosed
when a patient presented at hospital was automatically
assigned as having the outcome; a CAP diagnosed in
general practice had the outcome if the patient had a
hospital admission in the next 28 days. We chose all-
cause hospitalisation because we also wanted to capture
hospitalisations for events which pneumonia could have
precipitated in our older population, such as stroke,
myocardial infarctions and falls, or worsening of under-
lying comorbidities such as chronic obstructive pulmon-
ary disease or congestive heart failure.10
Other factors
Age was categorised in 5-year groups from 65 to 89 years,
and ≥90 years.
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Time period
Year of hospitalisation used a ﬁnancial year structure
(1 April to 31 March) to ensure respiratory pathogens
circulating throughout the winter were captured in the
same year. Year was then grouped as 1998–2000, 2001–
2003, 2004–2006, 2007–2008 and 2009–2010, to account
for health service changes such as the introduction of
payment-for-performance indicators in 2004 and
2009.11 12
Comorbidities and frailty factors
Code lists for the 19 comorbidities in the Charlson
Index and for additional cardiac, neurological and
immune disorders that could affect pneumonia disease
severity or a doctor’s decision to hospitalise were devised
by author SLT and at least one other clinical
epidemiologist.
Prevalidated frailty scores such as the frailty phenotype
or frailty index could not be utilised due to aspects of
each not being recorded in the electronic health
records used in this study (eg, grip strength and slow
gait speed from the phenotype and sucking problems
and poor muscle tone in neck from the index).13 14
Instead, a wide variety of factors identiﬁed in the frailty
index as associated with frailty, for which information
was potentially available in the databases, were consid-
ered. Authors ERCM and SLT devised Read and ICD-10
code lists and used other recording ﬁelds within the
data to capture health deﬁcits within the previous year
(eg, history of falls, inability to self-care) which were
likely to be recorded in patients’ health records, as well
as other factors that could increase the likelihood of
hospitalisation (eg, living alone).
The presence of chronic conditions (such as diabetes
or dementia) was determined using CPRD and HES
records from any point up to and including the CAP
incident date. For acute/potentially acute conditions
(myocardial infarction, stroke, congestive heart failure,
hemiplegia, falls, weight loss/undernutrition) which
could have occurred as a result of the CAP, records from
any point prior to but excluding the CAP incident date
itself were used as evidence of a pre-existing condition.
Terminal illness was deﬁned using Read and ICD-10
codes stating terminal illness, rather than speciﬁc condi-
tions. In addition, primary care information on referrals
to hospices was included.
Medications, vaccinations and health behaviours
Medications included oral steroids, inhaled steroids,
immunosuppressive drugs, statins and antibiotics. We
also considered inﬂuenza and pneumococcal vaccin-
ation status, and health behaviours such as smoking and
excessive alcohol consumption.
As is common when using routinely collected health
records, for all the factors aforementioned, the absence
of a code for a condition was assumed to represent
absence of the condition.
A full list of the factors considered, how they were
categorised and timescales used to determine if they
were present at CAP diagnosis, can be found in online
supplementary ﬁle A.
Main analyses
Some patients had more than one CAP event during the
study period. It is highly likely that decisions around
whether to hospitalise a patient after CAP were affected
by a previous history of CAP. Furthermore, decisions to
hospitalise may have been similar for patients within a
general practice, for example, due to local area service
provision. To account for this clustering at patient and
practice level, we used multilevel logistic regression
models for the binary hospitalisation outcome.15 The
model had three levels: CAP episodes nested within
patients who were nested within practices. The suitability
of the three-level model was assessed by comparing it to
simpler speciﬁcations (using likelihood ratio tests (lrt))
both before and after including explanatory factors in
the model.
First, minimally adjusted ORs of hospitalisation follow-
ing a CAP (adjusted for age, sex and year of CAP) were
produced for each of the factors of interest. The size of
these ORs and their 95% CIs were used to decide which
variables to include in later models. These variables
were grouped into (1) comorbidities; (2) frailty factors;
and (3) medications, vaccinations and health beha-
viours. We added the three groups of variables sequen-
tially to a model adjusted for age, sex and year of CAP,
according to each group’s hypothesised place on the
causal pathway to hospitalisation. This enabled examin-
ation of the independent effect of each comorbidity (in
the ‘comorbidity’ model), and how much of each
comorbidity’s effect was explained by resulting frailty
and/or medications (in subsequent models). A possible
interaction between age and sex on the odds of hospital-
isation was investigated in the ﬁnal (full) model, com-
paring full models with and without the interaction term
using an lrt.
To investigate the extent to which patient risk factors
for hospitalisation explained trends in the probability of
post-CAP hospitalisations, ORs for hospitalisation for
each temporal period relative to 2001–2003 were esti-
mated, controlling for changes in comorbidities and
other factors. Multilevel models produce cluster-speciﬁc
ORs of hospitalisation (ie, effects measured within each
cluster). When investigating the level of hospitalisation
after CAP over time, results at a population level were
deemed more useful. Thus, we used the predicted
cluster-level odds of hospitalisation derived from the
ﬁnal multilevel model to calculate the population
average of predicted percentages of CAPs hospitalised in
each year group.16
Further analyses
Records for smoking enable the recording of a negative
response (non-smoker), and so levels of missing data
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were able to be established for this variable. Smoking
status was more completely recorded over time, decreas-
ing from 26% missing data in 1998 to <1% by 2010 (see
online supplementary ﬁle B). Multiple imputation was
not considered appropriate as data were unlikely to be
missing at random, for example, with respect to
comorbidity status. Analyses including smoking as a cov-
ariate were therefore restricted to a subset of the data,
performing a complete case analysis of CAP episodes
with a recorded smoking status from 2007 onwards
(which included more than 97% of CAPs per year).
Trends in mortality in the 28 days after CAP were
assessed using the linked mortality data and multilevel
logistic regression modelling (as for hospitalisation).
Odds of mortality over time were adjusted for age and
sex, but not for comorbidities or other factors, to avoid
overadjustment of CAP severity resulting from under-
lying health deﬁcits.
Two other potential explanations for trends in hospi-
talisation were investigated. The length of hospital
admission for hospitalised patients over time (a further
potential proxy of severity of illness) was examined using
HES data. The pathway of care for each CAP episode
over time was assessed by examining method of admis-
sion data in HES, and whether there was a general prac-
tice consultation for CAP (or potential CAP) on the day
of diagnosis. We widened the deﬁnition of CAP in
general practice to any LRTI to allow for conservative
coding by general practitioners (GPs) in the absence of
radiographical conﬁrmation of pneumonia.17
All analyses were performed using Stata MP V.11.2.
RESULTS
Of 917 859 potentially eligible patients, 39 211 had at
least one recorded CAP and their 43 576 CAP illness
episodes were included in the study. The median age
at diagnosis was 81 years (lower-upper quartiles:
75–87 years) and 53% of CAPs were in females (table 1).
Most patients (91%) experienced one CAP, 7% of
patients had two episodes and 2% had 3–8 episodes.
The reason for admission was coded with an ICD-10
Chapter X code (Diseases of the respiratory system) for
95% of admissions throughout the study period, with
Chapter XVIII (Signs and symptoms not elsewhere clas-
siﬁed) and Chapter IX codes (Circulatory disease) each
contributing around 1% of admissions.
Risk factors for hospitalisation
After adjusting for age, sex and year, our study found
little evidence that hemiplegia, mild renal disease, self-
care problems, anxiety/depression, mobility issues, tired-
ness, history of falling or excessive alcohol consumption
were risk factors for hospitalisation, and these factors
were not included in subsequent analyses (see online
supplementary ﬁle C).
Results for the remaining 16 comorbidities, 6 frailty
factors and 7 medications/vaccinations are given in
ﬁgure 1 and in the online supplementary ﬁle C. The
ﬁgure reports the ﬁnal model in which ORs are mutu-
ally adjusted; the table reports minimally and then con-
secutively adjusted ORs in successive models.
Comorbidities
In the ﬁnal model, 12 comorbidities were associated with
increased odds of hospitalisation after CAP (ﬁgure 1).
Of the comorbidities common among this cohort,
chronic lung disease, ischaemic heart disease, congestive
heart failure, severe renal disease and diabetes (with and
without complications) were associated with a 25–82%
increased odds of hospitalisation. The greatest odds of
hospitalisation were found for less common conditions
such as metastatic cancer and other disorders of the
immune mechanism (adjusted ORs 2.46 and 2.49,
respectively). Only terminal illness and dementia
remained clearly associated with decreased odds of hos-
pitalisation. Comparison with earlier models indicated
that adjustment for frailty factors and medications made
little difference to effect estimates for individual
comorbidities except for those for connective tissue
disease (attenuated by medications) and dementia (atte-
nuated by frailty factors, online supplementary ﬁle C).
Frailty factors
Visual problems was the only frailty factor associated
with increased odds of hospitalisation in the ﬁnal
adjusted model, while the presence in the last year of
bedsores, low weight/poor nutrition or incontinence
had a negative effect on hospitalisation, as did residence
in a nursing home (ﬁgure 1).
Medications/vaccinations
Patients with a prescription for antibiotics in the previous
8–28 days were less likely to be hospitalised after CAP
than patients with no prescription in the previous
4 weeks, controlling for the other variables in the model.
Oral steroid use was associated with increased odds of
hospitalisation, but the strong effect of inhaled corticos-
teroids and other immunosuppressive medications
disappeared after adjusting for comorbidities (see online
supplementary ﬁle C). We did not observe a protective
effect of statin use against hospitalisation. Inﬂuenza
vaccination in the current inﬂuenza season lowered the
odds of hospitalisation after CAP in the ﬁnal adjusted
model by 25% compared with those who had never been
vaccinated. In contrast, receipt of pneumococcal vaccine
showed no protective effect, with evidence of slightly
increased odds among the group vaccinated ≥5 years
ago (compared with unvaccinated).
Age/sex
In the ﬁnal model, females remained at lower odds of
hospitalisation than males, and hospitalisation odds
increased with age up to 85–89 years. However, there was
evidence that the effect of age on hospitalisation varied
by sex (pinteraction<0.001). In contrast to men, women
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Table 1 Characteristics of the study population, factors of interest and hospitalisation within 28 days of CAP
Hospitalised within 28 days
n
Not hospitalised
n Total
All CAPs n (%) 33 321 (76.5) 10 255 (23.5) 43 576
Male n (%) 16 143 (79.5) 4151 (20.5) 20 294
Female n (%) 17 178 (73.8) 6104 (26.2) 23 282
Age (grouped) n (%)
65–69 3469 (75.9) 1099 (24.1) 4568
70–74 4703 (78.8) 1262 (21.2) 5965
75–79 6039 (78.4) 1663 (21.6) 7702
80–84 7227 (79.5) 1865 (20.5) 9092
85–89 6666 (76.6) 2038 (23.4) 8704
90+ 5217 (69.1) 2328 (30.9) 7545
Year of CAP (grouped) n (%)
1998–2000 4008 (57.7) 2944 (42.3) 6952
2001–2003 6266 (69.9) 2701 (30.1) 8967
2004–2006 8269 (79.2) 2173 (20.8) 10 442
2007–2008 7039 (83.7) 1372 (16.3) 8411
2009–2010 7739 (87.9) 1065 (12.1) 8804
Individual comorbidities n (%)
Ischaemic heart disease
Pre-MI 7261 (81.5) 1644 (18.5) 8905
Post-MI 4914 (83.2) 994 (16.8) 5908
Congestive heart failure 8289 (79.6) 2124 (20.4) 10 413
Peripheral vascular disease 4661 (82.7) 976 (17.3) 5637
Dementia 4526 (66.8) 2248 (33.2) 6774
Chronic lung disease 14 571 (83.4) 2905 (16.6) 17 476
Connective tissue disease 3347 (81.9) 740 (18.1) 4087
Peptic ulcer 3343 (81.1) 778 (18.9) 4121
Liver disease
Mild 241 (84.3) 45 (15.7) 286
Severe 165 (87.3) 24 (12.7) 189
Diabetes
Diabetes 4678 (81.3) 1076 (18.7) 5754
With complications 1633 (86.6) 253 (13.4) 1886
Hemiplegia 1243 (76.4) 384 (23.6) 1627
Cancer
Solid cancer 5208 (80) 1300 (20) 6508
Metastatic 1066 (83.9) 204 (16.1) 1270
Leukaemia/lymphoma 981 (85) 173 (15) 1154
Severe renal disease 7001 (88.6) 900 (11.4) 7901
Cerebrovascular disease 8338 (74.5) 2856 (25.5) 11 194
Neurological disease 2997 (73.1) 1103 (26.9) 4100
Disorders of the immune mechanism 243 (90) 27 (10) 270
Mild renal disease 401 (82.5) 85 (17.5) 486
Terminal illness 1190 (67.1) 584 (32.9) 1774
Frailty factors n (%)
Recent carer 1418 (79.6) 364 (20.4) 1782
Living arrangements
Not recorded 27 949 (77.6) 8070 (22.4) 36 019
Lives alone 1471 (81) 344 (19) 1815
Sheltered accommodation 477 (79) 127 (21) 604
Residential care 3424 (66.6) 1714 (33.4) 5138
Visual impairment 11 098 (78.8) 2984 (21.2) 14 082
Self-care 366 (79.7) 93 (20.3) 459
Anxious/depressed 2730 (76) 860 (24) 3590
Bedsore/ulcer 824 (59.7) 556 (40.3) 1380
Mobility issues 2072 (79) 552 (21) 2624
Tired 1957 (74.4) 672 (25.6) 2629
Low weight/poor nutrition 4460 (75.1) 1477 (24.9) 5937
Continued
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aged ≥90 years were not at increased odds of hospitalisa-
tion compared with women aged 65–69 years after
adjusting for comorbidities and other factors (table 2).
The three-level model remained the most appropriate
structure (compared with single or two-level) after the
addition of all other factors to the model (all p<0.001).
The effect of comorbidities on trends in post-CAP
hospitalisations
After adjusting for all factors and for clustering, a
marked increase in the percentage of CAP cases hospita-
lised over time remained, rising from 57% to 86% hospi-
talised over the study period. The wide range of
comorbidities and other factors identiﬁed as risk factors
for hospitalisation contributed very little to this increase
(table 3).
Smoking
In total, 17 008 CAP events between 2007 and 2010 were
included in the complete-case smoking analyses. After
adjusting for age and sex, smokers had nearly three times
the odds of being hospitalised than non-smokers
(OR=2.83, 95% CI 2.25 to 3.56) with ex-smokers at nearly
twice the odds (OR=1.88, 95% CI 1.59 to 2.23). After
adjusting for comorbidities, smokers had 96% higher
odds of hospitalisation than non-smokers, and ex-smokers
37% higher (see online supplementary ﬁle D).
Further analyses
The age-adjusted and sex-adjusted odds of dying in the
28 days post-CAP decreased progressively over the study
period, with patients in 2009–2010 having a 38% reduc-
tion in the odds of dying within 28 days of CAP com-
pared with those in 2001–2003 (table 4). Length of
hospital admission decreased slightly over the study
period, from 8 (IQR 4–16) days in 1998–2000 to 7 (IQR
3–13) days in 2009–2010 (table 4). The percentage of
short-term admissions (<2 days) increased over time
from 11.7% to 14.1%. The majority of admissions
(95.6%) occurred on the date of the CAP diagnosis.
Emergency admissions recorded as being via Accident
and Emergency (A&E) increased successively, from
50.6% of post-CAP admissions in 1998–2000 to 76.4% in
2009–2010. Conversely, emergency admissions coded as
arriving via a GP fell from 41.6% to 18.1%, and there
was a corresponding fall in the percentage of CAP
events with a CAP or potential CAP record in the GP
data, from 58% to 34%.
Table 1 Continued
Hospitalised within 28 days
n
Not hospitalised
n Total
Incontinence/catheter 3230 (71.7) 1274 (28.3) 4504
History of falling 4792 (76.4) 1484 (23.6) 6276
Excessive alcohol consumption
Any excess alcohol code 1720 (80.3) 423 (19.7) 2143
Medications n (%)
Immunosuppressants (other than steroids) in past 120 days 685 (85.3) 118 (14.7) 803
Inhaled corticosteroids
None pre-CAP 22 414 (73.6) 8023 (26.4) 30 437
Within 60 days 6864 (84.7) 1239 (15.3) 8103
Within 61–180 days 1620 (81.6) 366 (18.4) 1986
Within 181–365 days 597 (81.4) 136 (18.6) 733
More than 365 days ago 1826 (78.8) 491 (21.2) 2317
Antibiotics
None in previous 28 days 23 437 (77.2) 6926 (22.8) 30 363
In previous 1–7 days 5368 (76.9) 1610 (23.1) 6978
In previous 8–28 days 4516 (72.4) 1719 (27.6) 6235
Statins in previous 6 months 8829 (86.7) 1350 (13.3) 10 179
Oral steroids in previous 90 days 5242 (83) 1077 (17) 6319
Influenza vaccine receipt
No vaccine pre-CAP 4940 (69.7) 2143 (30.3) 7083
14–365 days pre-CAP 20 554 (76.2) 6420 (23.8) 26 974
Last season 5990 (75.5) 1949 (24.5) 7939
2–5 years pre-CAP 1846 (71.7) 728 (28.3) 2574
>5 years pre-CAP 656 (76.4) 203 (23.6) 859
Pneumococcal vaccine
No vaccine pre-CAP 13 126 (66.4) 6643 (33.6) 19 769
14–365 days pre-CAP 1872 (73.7) 669 (26.3) 2541
1–2 years pre-CAP 2095 (75.4) 682 (24.6) 2777
2–5 years pre-CAP 7260 (80.1) 1801 (19.9) 9061
>5 years pre-CAP 9633 (85.4) 1648 (14.6) 11 281
CAP, community-acquired pneumonia; MI, myocardial infarction.
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Figure 1 Mutually adjusted ORs (circles) with 95% CIs (lines) of hospitalisation in the 28 days after CAP for factors included in
the final model*. The model also contained year of CAP diagnosis, but the results for year are not presented. *Baseline
categories were age 65–69 years; condition or medication not present (for comorbidities, frailty factors, recent medications);
unvaccinated/no record of vaccination (for influenza and pneumococcal vaccination) (CAP, community-acquired pneumonia; MI,
myocardial infarction).
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DISCUSSION
This is the ﬁrst UK study to use large linked data sets to
explore the factors associated with hospitalisation
among CAP cases, and thus help identify high-risk
patients for proactive case management. The factors we
investigated had varying effects on hospitalisation. We
were able to identify a wide range of patient factors that
increased the odds of hospitalisation, including condi-
tions common in older populations such as chronic
lung disease, ischaemic heart disease, congestive heart
failure, severe renal disease and diabetes. Analysis of the
subset of data with near-complete recording of smoking
status illustrated that smoking is also a strong risk factor
for hospitalisation, independent of comorbidity status.
Factors associated with decreased likelihood of hospital-
isation included terminal illness, speciﬁc frailty factors
and receipt of residential care. Individuals who had
been recently vaccinated against inﬂuenza and those
with recent antibiotic treatment were also less likely be
hospitalised. An unexpected ﬁnding was that the oldest
women (but not men) in our study were not at
increased risk of hospitalisation compared with younger
women in adjusted analyses; one possible explanation
for this is a survivor effect among the oldest women.
Unlike previous studies that have reported pneumonia
hospitalisation trends, we were able to demonstrate that
hospitalisation after a CAP diagnosis is increasing inde-
pendently of any trends in CAP incidence.2 18 We add-
itionally found that this increase does not appear to be
driven by the underlying health and social issues of the
older population. The average predicted probability of
hospitalisation in the 28 days after CAP increased sub-
stantially in this population over the study period, from
57% to 86%, after extensive adjustment for changes in
the prevalence of patient factors. All-cause mortality in
the 28 days post-CAP and length of hospitalisation both
decreased over the study period, with an increasing pro-
portion of short-term (<2 day) admissions, suggesting
that the increase in hospitalisation was not linked to
increasing CAP severity. Owing to the lack of informa-
tion on illness severity in these data, we cannot ascertain
directly if less severely ill patients are being hospitalised
over time, or whether hospital treatment has helped
reduce mortality in the 28 days after admission.
We also found that over the study period progressively
lower proportions of patients arrived in A&E after refer-
ral from their GP or with evidence that the GP had seen
them for a LRTI on the day of CAP diagnosis, highlight-
ing changes in patients’ health-seeking behaviour.
Strengths
The use of large linked data sets meant that we could
distinguish between community and hospital-acquired
pneumonia and include non-hospitalised CAP episodes,
which enabled assessment of risk factors speciﬁcally for
hospitalisation. The very large linked data allowed thor-
ough investigation of individual comorbidities and other
variables, many of which are incompletely recorded or
unrecorded in hospital admission data. The advantage
of investigating individual comorbidities, compared with
using a summary comorbidity score such as the
Charlson score, is that we avoided masking of opposing
associations of individual comorbidities on hospitalisa-
tion. For example, a Charlson score of 1 is given to a
patient who has dementia, or to a patient with chronic
lung disease. According to our analysis, a patient with
dementia would have reduced odds of hospitalisation
after CAP, whereas a patient with chronic lung disease
would have increased odds. The linked data also allowed
assessment of trends in hospitalisation independent of
trends in CAP incidence, with detailed adjustment to
account for any changes in the prevalence of patient
Table 2 Results of the effect of age on post
community-acquired pneumonia hospitalisation, in males
and females
Age (years) Male OR (95% CI)* Female OR (95% CI)*
65–69 1 1
70–74 1.35 (1.13 to 1.61) 1.34 (1.10 to 1.61)
75–79 1.49 (1.26 to 1.76) 1.39 (1.16 to 1.66)
80–84 1.65 (1.40 to 1.96) 1.61 (1.35 to 1.93)
85–89 1.63 (1.36 to 1.94) 1.47 (1.23 to 1.75)
≥90 1.59 (1.31 to 1.94) 1.00 (0.84 to 1.19)
*Adjusted for: year, ischaemic heart disease, congestive heart
failure, peripheral vascular disease, dementia, chronic lung
disease, connective tissue disease, peptic ulcer, liver disease,
diabetes, cancer, leukaemia/lymphoma, severe renal disease,
cerebrovascular disease, neurological disease, disorders of the
immune mechanism, terminal illness, recent carer, place of
residence, vision problems, bed ulcer, underweight/nutritional
replacement, incontinence/catheter, immunosuppressants (other
than steroids), steroids, inhaled steroids, statins, antibiotics in
previous 28 days, influenza vaccine.
Table 3 Average predicted probability (%) of
hospitalisation within 28 days of community-acquired
pneumonia diagnosis, by year
Average predicted probability of
hospitalisation (%)
Year
No
adjustment
Adjusted for age,
sex and
comorbidities*
Full
model†
1998–2000 58 57 57
2001–2003 70 67 68
2004–2006 80 76 78
2007–2008 84 80 81
2009–2010 89 85 86
*Comorbidities: ischaemic heart disease, congestive heart failure,
peripheral vascular disease, dementia, chronic lung disease,
connective tissue disease, peptic ulcer, liver disease, diabetes,
cancer, leukaemia/lymphoma, severe renal disease,
cerebrovascular disease, neurological disease, disorders of the
immune mechanism, terminal illness.
†As for comorbidities, with addition of: recent carer, place of
residence, vision problems, bed ulcer, underweight/nutritional
replacement, incontinence/catheter, immunosuppressants (other
than steroids), steroids, inhaled steroids, statins, antibiotics in
previous 28 days, influenza vaccine.
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risk factors for hospitalisation over time. The linked
CPRD population is representative of the population of
England, making our ﬁndings generalisable to the popu-
lation at large, and the linked hospital data enabled us
to identify the outcome (hospitalisation) with minimal
misclassiﬁcation. Further linkage to central mortality
records allowed us to estimate mortality without restrict-
ing analyses to the subset of patients who died in hos-
pital, thus avoiding changes in mortality over time due
simply to changes in the relative proportions of patients
who died in and outside hospital.
In contrast to previous studies that used only the ﬁrst
CAP episode in a year, we included patients with
repeated episodes of CAP.18 19 The association between
speciﬁc comorbidities and hospitalisation could be par-
ticularly strong in this small but important subset of
patients, and inclusion of their multiple episodes
avoided potential underestimation of these associations.
Limitations
Validity of recorded diagnoses is generally high in
CPRD, and comorbidities and other risk factors that
were only recorded after the hospitalisation were not
included; thus, any misclassiﬁcation of these factors is
likely to be relatively small and non-differential with
respect to the outcome.20 The linked data enriched our
Table 4 Post-CAP mortality, length of hospital admission and consultation behaviour on the day of CAP diagnosis, over time
Year
1998–2000 2001–2003 2004–2006 2007–2008 2009–2010
OR for mortality within
28 days of CAP
diagnosis*
1.01 (0.93 to 1.10) 1 0.84 (0.78 to 0.91) 0.73 (0.67 to 0.79) 0.62 (0.57 to 0.68)
Length of hospital
admission median,
(lower-upper quartile),
days
8 (4–16) 8 (4–17) 8 (4–15) 7 (3–14) 7 (3–13)
0–2 468 (11.7) 660 (10.5) 981 (11.9) 999 (14.2) 1093 (14.1)
2–6 1138 (28.4) 1831 (29.2) 2595 (31.4) 2364 (33.6) 2731 (35.3)
7–13 1145 (28.6) 1737 (27.7) 2311 (27.9) 1827 (26) 1987 (25.7)
≥14 1256 (31.3) 2037 (32.5) 2383 (28.8) 1848 (26.3) 1930 (24.9)
Reason for admission, n (% of those hospitalised)
Emergency: via A&E 2027 (50.6) 3760 (60) 5559 (67.2) 5073 (72.1) 5914 (76.4)
Emergency: via GP 1666 (41.6) 2016 (32.2) 2231 (27) 1522 (21.6) 1402 (18.1)
Emergency: via bed
bureau
102 (2.5) 107 (1.7) 125 (1.5) 114 (1.6) 121 (1.6)
Emergency: via
consultant outpatient
clinic
26 (0.6) 42 (0.7) 43 (0.5) 41 (0.6) 42 (0.5)
Emergency: other
means (including A&E
from another place)
66 (1.6) 135 (2.2) 143 (1.7) 122 (1.7) 127 (1.6)
Transfer
(non-emergency),
elective, not known
120 (3) 205 (3.3) 169 (2) 166 (2.4) 135 (1.7)
Admitting diagnosis
ICD10 Chapter X—
diseases of the
respiratory system
3798 (94.8) 5979 (95.4) 7939 (96) 6743 (95.8) 7426 (95.9)
Hospitalisations on
CAP diagnosis date, n
(% of those
hospitalised)
3718 (92.8) 5893 (94.1) 7896 (95.5) 6804 (96.7) 7539 (97.4)
Relevant diagnosis on CAP date† (n, % all CAP)
CPRD only 3234 (46.5) 3074 (34.3) 2546 (24.4) 1607 (19.1) 1265 (14.4)
HES only 2909 (41.8) 4644 (51.8) 5990 (57.4) 5266 (62.6) 5787 (65.7)
CPRD and HES 809 (11.6) 1249 (13.9) 1906 (18.3) 1538 (18.3) 1752 (19.9)
*Adjusted for age and sex using three-level model.
†General practice records included LRTI records as ‘potential CAP’, to allow for potentially conservative coding by GPs in the absence of
radiographical confirmation of pneumonia (see Results section). HES records included any hospital admission record.
A&E, Accident and Emergency; CAP, community-acquired pneumonia; CPRD, Clinical Practice Research Datalink; GP, general practitioner;
HES, Hospital Episode Statistics; ICD, International Classification of Diseases; LRTI, lower respiratory tract infection.
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overall comorbidity coding, but smoking histories were
under-recorded in the earlier years of the study period.
The introduction of the Quality Outcomes Framework
(QOF) in 2004 has improved the recording of smoking
status in GP records, and analysis of the subset of data
with near-full recording of smoking indicated its import-
ance as a risk factor for hospitalisation after CAP.
Similarly, while the use of GP data enabled investigation
of some factors associated with frailty, these factors were
not frequently recorded by GPs which limited our ability
to assess fully their association with hospitalisation.
Owing to the frailty indicators included in the data, we
were unable to use an established measure of frailty
such as the frailty phenotype or frailty index.13 14
However, the frailty index includes several of the
comorbidities we included individually in our model,
such as diabetes, myocardial infarction and lung disease,
and so use of this score may have led to overadjustment
for these other important conditions. We examined a
wide variety of variables; thus, estimates in the ﬁnal
model with a 95% CI close to including the null value
should be interpreted with caution.
The HES pneumonia diagnoses used in this study
have not been validated. There have been small loca-
lised reports of overdiagnosis of pneumonia in English
hospitals, but trends over time at a national level have
not been reported.21–23 As such we cannot exclude that
overdiagnosis could have played a role in the increasing
level of hospitalisation after CAP identiﬁed in this study.
The forthcoming British Thoracic Society audit of CAP
diagnoses will help to clarify this issue. Nevertheless, it is
likely that the majority of these patients had a respira-
tory illness that was considered severe enough to merit
hospitalisation, and these are of public health
importance.
The data sources used in this analysis did not contain
direct measures of pneumonia severity, such as those in
the CURB score, and so severity of illness could not be
measured directly.24 However, our aim was to establish
patients’ pre-existing conditions which contributed to
the increase in hospitalisation over time, not the mech-
anism by which this occurred (either by altering severity
of CAP or by other means), and so we do not feel this
detracts from our study ﬁndings. Furthermore, a recent
systematic review highlighted suboptimal performance
of CURB scores for oldest patients, and stressed the
need to focus more on the presence of comorbidities
and frailty in these patients.25 Similarly, due to the
nature of the coding used in these data, we were not
able to examine the severity of many of the comorbid-
ities we investigated, and so could not directly assess
whether increasing severity of these comorbidities over
time could have explained some of the increase in hos-
pitalisations during the study period. However, where we
could distinguish categories of severity (eg, for diabetes,
liver disease, renal disease and ischaemic heart disease),
the likelihood of hospitalisation was very similar for
those with severe and milder manifestations of the
condition, and adjustment for these factors did not
materially affect increasing hospitalisations.
Findings in relation to other studies
We have previously shown that CAP incidence is rising
among older individuals in the UK.6 This study conﬁrms
that hospitalisation following a CAP diagnosis is also
increasing, with a growing percentage of cases hospita-
lised within 28 days of diagnosis. Our ﬁndings enhance
those from previous studies that used stand-alone hospi-
talisation data, which have shown increasing hospitalisa-
tions for pneumonia without distinguishing increasing
CAP incidence from an increasing tendency to hospital-
ise patients with CAP.2 18 In particular, our analyses of
hospitalisation trends update and extend those of a pre-
vious English study, which reported increasing pneumo-
nia hospitalisation rates between 1997 and 2004 after
less extensive adjustment for comorbidities, using the
Charlson Index.18 Other studies that have investigated
individual risk factors among older patients with CAP or
LRTI have mostly been small and included fewer factors;
some used hospitalisation or death as a composite
outcome, which will obscure the opposing effects of con-
ditions such as dementia or terminal care on these two
outcomes.19 26–29 Our ﬁnding that inﬂuenza vaccine
receipt is associated with protection against hospitalisa-
tion after CAP is also consistent with the direction of
effect shown in previous studies of inﬂuenza vaccine
effectiveness against hospitalised CAP,30 31 and studies
showing a relative lack of long-term protection of
pneumococcal vaccine, especially among those with
underlying health conditions.32 33 Our ﬁndings also add
to those from a recent systematic review, which high-
lighted between-study heterogeneity in the association
between statin use and outcomes of pneumonia.34 The
reduction in mortality seen over the study period echoes
that from the earlier English study which focused on
in-hospital mortality, as well as CAP mortality studies
from Europe and the USA.18 35 36
Meaning, explanations and implications for future
research
The risk factors identiﬁed in this study will be of
beneﬁt to clinicians managing patients in primary care
settings, by helping to identify patients at high risk of
unplanned admission to hospital who are in need of
proactive case management. Our ﬁndings will further
inform discussions with these patients about protecting
against infection risk and seeking early treatment for
symptoms.
Frailty is currently a health priority in the UK. The
requirement in the 2014 general practice contract for
increased identiﬁcation of vulnerable older members of
the practice population may result in better recording of
frailty in general practice data and enable more thor-
ough investigation of its effects on hospitalisation in
future research.37 The latter will be helped by a new
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primary care electronic Frailty Index, currently under
development in England.38
Despite their importance in identifying high-risk
patients, our adjusted analyses show that increasing
prevalence of comorbidities and frailty are not driving
the increase in hospitalisation rates. Declining mortality
and length of hospital stay indicate that this is not due
to increasing disease severity. What then explains the
increasing hospitalisation trend? The guidelines for
management of CAP issued by the British Thoracic
Society have not changed signiﬁcantly over the study
period.39 40 However, the diagnostic accuracy of pneu-
monia may have changed over time. An emergency
department-based US study found that the accuracy of
pneumonia diagnoses decreased after the change of a
core quality measure (time to ﬁrst antibiotic dose) from
8 to 4 h.41 In England, the introduction of the 4 h A&E
waiting time target in 2004 could have had a similar
effect.
In addition, changes to service provision and utilisa-
tion have been highlighted as playing a role in the
increase, with the change in out-of-hours access to GPs
during the study period.42 The effect of this is difﬁcult
to measure directly, but we found decreasing emergency
admissions over time arriving via a GP, and a decreasing
proportion of patients with a CAP or potential CAP
recorded by their general practice on their CAP diagno-
sis date. Studies have also shown that the increase in
emergency admissions among older individuals in
England is not restricted to pneumonia but are seen for
a range of other conditions, and that the percentage of
patients who attended A&E and were then admitted
rose by over a third between 2003 and 2012, with 75% of
this rise attributed to increasing emergency admissions
and 25% to an increase in A&E attendance.43 Thus, an
increasing tendency to hospitalise, coupled with an
increasing inclination of patients to present to A&E
rather than to their general practice, may be a main
driver of the growth in hospitalisation after CAP. It
would be interesting to compare our results with those
from equally detailed studies that use linked data to
investigate risk factors and hospitalisation trends for
other conditions, such as COPD or cellulitis. Results
from these studies would allow further interpretation of
whether increasing hospitalisation and decreasing
primary care consultation trends are not speciﬁc to CAP
among older adults.
Our study, based on very large numbers (minimising
random error) and with the ability to adjust hospitalisation
rates for many factors, supports the argument that focus-
ing on high-risk patients, while important for risk stratiﬁca-
tion, will not appreciably reduce emergency admissions.42
If the incidence of CAP among those aged ≥65 years also
continues to increase, these combined trends will place a
joint expanding burden on the health service.
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